Why the study?
Does cyclooxygenase inhibition with indomethacin alter forearm vascular responses to serotonin in healthy male volunteers?
Does cyclooxygenase inhibition with indomethacin alter forearm vascular responses to serotonin in healthy male volunteers?
Cyclooxygenase products do not appear to mediate forearm vascular responses to serotonin in healthy humans.
Indomethacin does not alter serotonin forearm responses in healthy men; leaves open COX mediation in disease and requires patient studies.
The involvement of cyclooxygenase-derived substances in the forearm arteriolar responses to serotonin was determined in 10 healthy male volunteers. Serotonin was infused in five incremental doses (0.003-30 micrograms min-1) for 2 min each into the brachial artery of the non-dominant forearm. Forearm blood flow (FBF) responses to each dose were measured by strain-gauge venous occlusion plethysmography. The cyclooxygenase inhibitor indomethacin (100 mg) was administered orally following the serotonin infusions. After 90 min the serotonin infusions were repeated and FBF responses measured. Serotonin caused a biphasic response with vasodilatation occurring at low doses (0.003-3 micrograms min-1, P < 0.01) and vasoconstriction occurring at the highest dose (P < 0.01). There was no significant difference in vascular response to serotonin following cyclooxygenase inhibition. In conclusion, cyclooxygenase products are not involved in the forearm vascular responses to serotonin in healthy human subjects.
No takes yet. Share an insight, caveat, or question.
Nugent et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: